Medicamen Biotech Limited — Others, 26-03-2025: Shareholders meeting

Medicamen Biotech Limited conducted an Extraordinary General Meeting (EGM) through video conferencing, where shareholders discussed key resolutions, including the issuance of 1.3 million equity shares and 655,000 fully convertible warrants on a preferential basis to both non-promoters and promoters. The meeting saw significant participation, ensuring shareholder engagement in decision-making. The voting results will be disclosed once finalized. This proactive move may signal the company's intention to enhance capital and strategic flexibility, likely fostering a positive outlook among investors regarding growth potential.